{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:08:01Z","timestamp":1788826081498,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.htct.2026.106448","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:14:51Z","timestamp":1775520891000},"page":"106448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of vaccine-induced antibody responses against SARS-CoV-2 in multiple myeloma patients from the northeastern region of Mexico"],"prefix":"10.1016","volume":"48","author":[{"given":"Rosario","family":"Salazar-Riojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila M.","family":"Alvarado-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6515-6063","authenticated-orcid":false,"given":"Mar\u00eda L.","family":"Ruiz-de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Nefertiti","family":"Castro-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina E.","family":"Vazquez-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-6427","authenticated-orcid":false,"given":"David","family":"Gomez-Almaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4505-4657","authenticated-orcid":false,"given":"Adrian G.","family":"Rosas-Taraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2026.106448_bib0001","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","article-title":"Immunodeficiency and immunotherapy in multiple myeloma","volume":"138","author":"Pratt","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2026.106448_bib0002","article-title":"Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls","volume":"14","author":"Bitoun","year":"2021","journal-title":"J Hematol Oncol BioMed Cent Ltd"},{"key":"10.1016\/j.htct.2026.106448_bib0003","volume":"5","author":"Gavriatopoulou","year":"2021"},{"key":"10.1016\/j.htct.2026.106448_bib0004","doi-asserted-by":"crossref","unstructured":"Ratta M., Fagnoni F., Curti A., Vescovini R., Sansoni P., Oliviero B., et al. Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6 [Internet]. 2002. Available from: http:\/\/ashpublications.org\/blood\/article-pdf\/100\/1\/230\/1683963\/h81302000230.pdf","DOI":"10.1182\/blood.V100.1.230"},{"key":"10.1016\/j.htct.2026.106448_bib0005","first-page":"17","article-title":"Third dose of an mRNA COVID-19 vaccine for patients with multiple myeloma","author":"Goldwater","year":"2023","journal-title":"Clin Infect Pr"},{"issue":"5","key":"10.1016\/j.htct.2026.106448_bib0006","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12185-022-03300-4","article-title":"Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma","volume":"115","author":"Terao","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.htct.2026.106448_bib0007","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.21.02257","article-title":"Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma [Internet]","volume":"40","author":"Nooka","year":"2022","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.htct.2026.106448_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00546-9","article-title":"Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab","volume":"11","author":"Cattaneo","year":"2021","journal-title":"Blood Cancer J"},{"issue":"7914","key":"10.1016\/j.htct.2026.106448_bib0009","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.htct.2026.106448_bib0010","article-title":"SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes","volume":"7","author":"Brewer","year":"2022"},{"issue":"1","key":"10.1016\/j.htct.2026.106448_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19073-z","article-title":"Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies","volume":"12","author":"Takahashi","year":"2022","journal-title":"Sci Rep"},{"issue":"1, ene\u2013feb","key":"10.1016\/j.htct.2026.106448_bib0012","doi-asserted-by":"crossref","first-page":"78","DOI":"10.21149\/14877","article-title":"The impact of the Covid-19 vaccination policy in Mexico. A quasi-experimental effectiveness evaluation of a multi-vaccine strategy","volume":"66","author":"Bautista-Arredondo","year":"2023","journal-title":"Salud Publica Mex [Internet]"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926001951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926001951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:24:43Z","timestamp":1788823483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926001951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2531137926001951"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106448","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of vaccine-induced antibody responses against SARS-CoV-2 in multiple myeloma patients from the northeastern region of Mexico","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106448"}}